BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

494 related articles for article (PubMed ID: 6797816)

  • 1. Oral thyrotropin-releasing hormone (TRH) test in acromegaly.
    Marek J; Límanová Z; Srámková J
    Endokrinologie; 1981 Oct; 78(1):57-66. PubMed ID: 6797816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pituitary-thyroid axis in acromegaly.
    Eskildsen PC; Kruse A; Kirkegaard C
    Horm Metab Res; 1988 Dec; 20(12):755-7. PubMed ID: 3146541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naloxone influence on the growth hormone, prolactin and thyrotropin response to thyrotropin releasing hormone in acromegalic patients.
    De Marinis L; Mancini A; Zuppi P; Fiumara C; Conte G; Sammartano L; Fabrizi ML; Valle D
    Exp Clin Endocrinol Diabetes; 1996; 104(1):67-71. PubMed ID: 8750573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum thyrotropin and prolactin in the syndrome of generalized resistance to thyroid hormone: responses to thyrotropin-releasing hormone stimulation and short term triiodothyronine suppression.
    Sarne DH; Sobieszczyk S; Ain KB; Refetoff S
    J Clin Endocrinol Metab; 1990 May; 70(5):1305-11. PubMed ID: 2110573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of repetitive administration of thyrotropin-releasing hormone at short intervals in acromegaly.
    Losa M; Alba-Roth J; Sobieszczyk S; Schopohl J; Müller OA; von Werder K
    Acta Endocrinol (Copenh); 1989 Mar; 120(3):383-9. PubMed ID: 2494827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human prolactin and thyrotropin concentrations in the serums of normal and hypopituitary children before and after the administration of synthetic thyrotropin-releasing hormone.
    Foley TP; Jacobs LS; Hoffman W; Daughaday WH; Blizzard RM
    J Clin Invest; 1972 Aug; 51(8):2143-50. PubMed ID: 4626583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum levels of thyrotropin, prolactin, growth hormone, triiodothyronine and thyroxine after oral administration of thyrotropin releasing hormone in hypothyroid and hyperthyroid patients.
    Nedvídková J; Felt V
    Endokrinologie; 1976; 68(2):175-82. PubMed ID: 827434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repetitive administration of thyrotropin-releasing hormone results in small elevations of serum thyroid hormones and in marked inhibition of thyrotropin response.
    Snyder PJ; Utiger RD
    J Clin Invest; 1973 Sep; 52(9):2305-12. PubMed ID: 4199417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term treatment of acromegaly with Sandostatin (SMS 201-995). Normalization of most anomalous growth hormone responses.
    Pieters GF; van Liessum PA; Smals AG; van Gennep JA; Benraad TJ; Kloppenborg PW
    Acta Endocrinol Suppl (Copenh); 1987; 286():9-18. PubMed ID: 2892339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central hypothyroidism--various types of TSH responses to TRH stimulation.
    Trejbal D; Sulla I; Trejbalová L; Lazúrová I; Schwartz P; Machánová Y
    Endocr Regul; 1994 Mar; 28(1):35-40. PubMed ID: 7949012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disparity of thyrotropin (TSH) and prolactin responses to TSH-releasing hormone in obesity.
    Donders SH; Pieters GF; Heevel JG; Ross HA; Smals AG; Kloppenborg PW
    J Clin Endocrinol Metab; 1985 Jul; 61(1):56-9. PubMed ID: 3923032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of dexamethasone on prolactin and TSH responses to TRH and metoclopramide in man.
    Sowers JR; Carlson HE; Brautbar N; Hershman JM
    J Clin Endocrinol Metab; 1977 Feb; 44(2):237-41. PubMed ID: 402375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum thyrotropin response to combined arginine and thyrotropin-releasing hormone administration provides evidence for an altered somatostatinergic tone in acromegaly.
    Merola B; Colao A; Cataldi M; Rossi E; Longobardi S; Caruso E; Lombardi G
    Horm Res; 1992; 37(1-2):7-13. PubMed ID: 1356902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of acute infusion of erythropoietin on paradoxical responses of growth hormone to thyrotropin-releasing hormone in acromegalic patients.
    Díez JJ; Iglesias P; Sastre J; Gómez-Pan A
    Eur J Endocrinol; 2000 Aug; 143(2):203-11. PubMed ID: 10913939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma thyrotropin-releasing hormone, prolactin, thyrotropin, and thyroxine concentrations following the intravenous or oral administration of thyrotropin-releasing hormone.
    Andreassen B; Huth J; Tyson JE
    Am J Obstet Gynecol; 1979 Nov; 135(6):737-42. PubMed ID: 115316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyroid-stimulating hormone, prolactin, and growth hormone response to thyrotropin-releasing hormone in treated children with congenital hypothyroidism.
    Sack J; Shafrir Y; Urbach D; Amado O
    Pediatr Res; 1985 Oct; 19(10):1037-9. PubMed ID: 3932951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral administration of TRH in puerperal women: effect on insufficient lactation, thyroid hormones and on the responses of TSH and prolactin to intravenous TRH.
    Ylikorkala O; Kivinen S; Kauppila A
    Acta Endocrinol (Copenh); 1980 Apr; 93(4):413-8. PubMed ID: 6770567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contradictory clinical implications between paradoxical growth hormone responses to thyrotropin-releasing hormone and those to vasoactive intestinal peptide and luteinizing hormone-releasing hormone in acromegaly.
    Watanobe H; Tamura T; Sasaki S; Takebe K
    Neuropeptides; 1993 Dec; 25(6):363-75. PubMed ID: 8127416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of long-term low dose thyrotropin-releasing hormone infusions on serum thyrotropin and prolactin concentrations in man.
    Spencer CA; Greenstadt MA; Wheeler WS; Kletzky OA; Nicoloff JT
    J Clin Endocrinol Metab; 1980 Oct; 51(4):771-5. PubMed ID: 6774994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyrotropin-releasing hormone in critical illness: from a dopamine-dependent test to a strategy for increasing low serum triiodothyronine, prolactin, and growth hormone concentrations.
    Van den Berghe G; de Zegher F; Vlasselaers D; Schetz M; Verwaest C; Ferdinande P; Lauwers P
    Crit Care Med; 1996 Apr; 24(4):590-5. PubMed ID: 8612408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.